For The Better

To say the stock has been on a bumpy ride over the years would be a huge understatement.

The conglomerate has returned nearly 20% annually since Buffett took over, but is it still a worthwhile buy today?

Tesla issued another disappointing earnings report.

Its new approach to treating cancer is more than just a nibble around the edges.

Netflix has delivered four consecutive quarters of accelerating growth. Is it time to buy the stock?

2024 could be an important year for the biotech.

Even though the stock market just hit new highs, I’m still buying.

Can the beaten-down stock turn things around?

A proposed Fiscal Commission could recommend ways to bolster Social Security. But some fear it could also push for benefit cuts.

VinFast’s Q4 and full-year deliveries are a mix of good and bad. Here’s what you need to know.

Eli Lilly is the world’s largest healthcare company by market cap, and the 10th most valuable business in the world.

The stock has rallied from its all-time low, but this business is still not generating a profit.

Meta Platforms is going all-in on Nvidia’s H100 GPUs through the end of the year.

Ford and Rivian both make EV trucks. Does Ford’s recent move with the F-150 Lightning spell bad news for Rivian’s R1T?

Is its huge 12% yield a warning or an opportunity? One thing is sure: The past isn’t a reliable gauge of the future anymore.

Which of the two beaten-down stocks offers investors a better deal?

The most explosive stock in Berkshire’s portfolio today might be one you’ve never heard of.

These companies have the qualities of long-term winners, and their stocks sell at a big discount right now.

Should income investors prefer the soda giant or the home improvement leader?

Many investors will want to consider owning these stocks for a long time.